SCHEMBL22207263

SCHEMBL22207263

CCCCCCCCOC(=O)C(C)Oc1cccc(O)c1

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
SMPD1 P17405 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28612345 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL22207225 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL28919858 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL22207181 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL22207269 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL22207454 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL22207122 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL22207423 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL22207127 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1
SCHEMBL29408352 1.00 TSHR (0.46) TSHRALDH1A1LMNASMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378205-B2 Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof BASF SE (DE) 2025-08-05 US disclosed
US-12291509-B2 Process for the preparation of UV absorbers BASF SE (DE) 2025-05-06 US disclosed
EP-3908576-B1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF SE (DE) 2023-03-08 EP disclosed
US-20220119357-A1 A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF BASF SE (DE) 2022-04-21 US disclosed
US-20220064129-A1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF CHEMICALS INDIA PVT. LTD. (IN) 2022-03-03 US disclosed
EP-3908576-A1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF SE (DE) 2021-11-17 EP disclosed
EP-3908633-A1 A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF BASF SE (DE) 2021-11-17 EP disclosed
CN-113260679-A Process for preparing triazine intermediates and process for preparing UV absorbers thereof 巴斯夫欧洲公司 2021-08-13 CN disclosed
CN-113260611-A Method for producing UV absorbers 巴斯夫欧洲公司 2021-08-13 CN disclosed
WO-2020144093-A1 A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF BASF SE (DE) 2020-07-16 WO disclosed
WO-2020144094-A1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF SE (DE) 2020-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119357-A1 A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF DHPS, NISCH, UNG TSHR 1439/4885ALDH1A1 529/4885LMNA 1696/4885
US-12378205-B2 Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof DHPS, UNG, UMPS TSHR 1518/4885ALDH1A1 606/4885LMNA 1744/4885
US-20220064129-A1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS UNG, ERCC4, UROD TSHR 3632/4885ALDH1A1 536/4885LMNA 1785/4885
US-12291509-B2 Process for the preparation of UV absorbers UNG, UROD, ERCC4 TSHR 3523/4885ALDH1A1 673/4885LMNA 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.